Literature DB >> 8725259

Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis.

R M van Elburg1, J J Uil, W M van Aalderen, C J Mulder, H S Heymans.   

Abstract

Disturbances of the intestinal integrity, reflected by an increased intestinal permeability, are reported in cystic fibrosis (CF). Controversy exists whether the increased intestinal permeability is due to CF itself or a consequence of the concomitant exocrine pancreatic insufficiency (PI). We measured intestinal permeability by the sugar absorption test in 32 PI patients: 20 CF-PI, 12 nonCF-PI with chronic pancreatitis, and 50 controls. In the sugar absorption test, the lactulose/mannitol ratio is measured in 5-h urine samples after oral ingestion of a solution of lactulose and mannitol, hyperosmolar by the addition of sucrose. The lactulose/mannitol ratio was increased in both CF-PI and nonCF-PI versus controls (p < 0.0001). In CF, the L/M ratio and permeability for lactulose and mannitol did not change by increasing pancreatic enzyme supplementation by 30-50% for 2 wk (p = 0.74, p = 0.97, p = 0.74, respectively) nor by decreasing the osmolarity of the test solution by 75% (p = 0.24, p = 0.10, p = 0.39, respectively). We conclude that an increased intestinal permeability in CF is probably a consequence of PI and is not related to the dose of pancreatic enzyme supplementation nor the osmolarity of the test solution. The increase is due to an increased permeability for lactulose which might point toward a defect in the tight junctions of the villi and/or crypts. The cause of the increased intestinal permeability in the presence of PI is still unclear. An increased intestinal permeability points toward an impaired functional integrity of the small bowel, which may contribute to gastrointestinal dysfunction in CF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725259     DOI: 10.1203/00006450-199606000-00010

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Intestinal permeability in relation to birth weight and gestational and postnatal age.

Authors:  R M van Elburg; W P F Fetter; C M Bunkers; H S A Heymans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

2.  Minimal enteral feeding, fetal blood flow pulsatility, and postnatal intestinal permeability in preterm infants with intrauterine growth retardation.

Authors:  R M van Elburg; A van den Berg; C M Bunkers; R A van Lingen; E W A Smink; J van Eyck; W P F Fetter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

Review 3.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

Review 4.  Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials.

Authors:  Zeinab Nikniaz; Leila Nikniaz; Nemat Bilan; Mohammad Hossein Somi; Elnaz Faramarzi
Journal:  World J Pediatr       Date:  2017-04-29       Impact factor: 2.764

Review 5.  The CF gastrointestinal microbiome: Structure and clinical impact.

Authors:  Geraint B Rogers; Michael R Narkewicz; Lucas R Hoffman
Journal:  Pediatr Pulmonol       Date:  2016-10

6.  Disrupted tight junctions in the small intestine of cystic fibrosis mice.

Authors:  Robert C De Lisle
Journal:  Cell Tissue Res       Date:  2013-10-30       Impact factor: 5.249

7.  Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.

Authors:  Thomas Flass; Suhong Tong; Daniel N Frank; Brandie D Wagner; Charles E Robertson; Cassandra Vogel Kotter; Ronald J Sokol; Edith Zemanick; Frank Accurso; Edward J Hoffenberg; Michael R Narkewicz
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Evidence for a Cystic Fibrosis Enteropathy.

Authors:  Marlou P M Adriaanse; Linda J T M van der Sande; Anita M van den Neucker; Paul P C A Menheere; Edward Dompeling; Wim A Buurman; Anita C E Vreugdenhil
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

9.  Effects of probiotics on quality of life in children with cystic fibrosis; a randomized controlled trial.

Authors:  Seyed-Ali Jafari; Atieh Mehdizadeh-Hakkak; Hamid-Reza Kianifar; Paria Hebrani; Hamid Ahanchian; Elaheh Abbasnejad
Journal:  Iran J Pediatr       Date:  2013-12       Impact factor: 0.364

10.  CFTR dysregulation drives active selection of the gut microbiome.

Authors:  Stacey M Meeker; Kevin S Mears; Naseer Sangwan; Mitchell J Brittnacher; Eli J Weiss; Piper M Treuting; Nicholas Tolley; Christopher E Pope; Kyle R Hager; Anh T Vo; Jisun Paik; Charles W Frevert; Hillary S Hayden; Lucas R Hoffman; Samuel I Miller; Adeline M Hajjar
Journal:  PLoS Pathog       Date:  2020-01-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.